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Domestic radon exposure is widespread, and
estimates suggest that it is a major contribu-
tor to the national burden of lung cancer
(1). Currently, the best available data upon
which to base a risk assessment ofresidential
radon exposure are derived from mining
studies (2-5). Such studies have clearly
established radon as a lung carcinogen, with
consistent relative risk levels demonstrating
a clear dose-dependent relationship between
exposure and lung cancer. Nonetheless, ade-
quate risk estimates derived directly from
the residential environment are not yet avail-
able. Consequently, many studies have been
undertaken tO directly estimate the effect of
domestic radon exposure. As demonstrated
by Lubin et al. (6), detection oflung cancer
attributable to radon will require large sam-
ple sizes and accurate exposure estimates, as
well as sound research design. However,
many of the studies published to date have
been inadequate in one respect or another.
Some have been ecologic in design rather
than case-control (7-10); some have suf-
fered from small sample sizes (11-13), inad-
equate exposure assessment (14,15), or from
relatively low and homogeneous exposure
levels (16,17), and most have included
smokers, which may have obscured the
effect ofradon.
Critical summaries ofpublished studies
have been reported (18,19). There are
approximately 20 current studies of
domestic radon and lung cancer risk which
include over 12,000 lung cancer cases and
19,000 referents (20). While these studies
may have corrected many of the deficien-
cies of the earlier studies, there remains a
paucity ofsubjects who are not current or
former smokers. Thus, results from these
studies will primarily reflect the relation-
ship between lung cancer and radon
among smokers. However, depending on
the underlying joint effect between radon
and smoking, the efficiency ofthese inves-
tigations may be compromised. In fact, the
ability of these studies to detect the effect
ofradon at risk levels with significant pub-
lic health consequences could be obscured
by the presence of the more potent car-
cinogen.
If the joint effect of cigarette smoking
and radon exposure is multiplicative, then
the relative risk of lung cancer due to
radon will be the same among smokers and
nonsmokers. Under those conditions, an
epidemiologic studywould have equivalent
power or require equal sample sizes
whether carried out among smokers, non-
smokers, or both. However, ifthe relation-
ship is not multiplicative, then differences
in power would result that could have a
profound effect on the underlying levels of
risk that could be detected with a
case-control study.
Although the notion that the model of
interaction between risk factors has an
important impact on study design and sta-
tistical power is not novel (21,22), it is fre-
quently not addressed in the design of
investigations. In this paper, this notion
will be illustrated with the example of
radon and smoking, using a computer
model to determine sample-size require-
ments. Sample size is a major limiting fac-
tor in the ability of an investigation to
detect the carcinogenic effect ofresidential
radon. Correspondingly, this analysis will
demonstrate that if the true underlying
joint effect is less than multiplicative, then
studies among never-smokers may be more
cost-effective than those among mixed
smoking and nonsmoking populations.
Such studies could be undertaken at indi-
vidual institutions with the ability to iden-
tify adequate numbers of never-smokers
over the course ofseveral years, or could be
undertaken at multiple institutions.
Joint Effect and Relative Risk
Currently, the true nature ofthe joint car-
cinogenic effect of radon and smoking is
unknown-it could conceivably range
from supramultiplicative to subadditive. A
recent analysis of 11 underground mining
studies (3) provides the largest database for
estimating the joint effect of radon and
smoking. While the joint effect varies
among the six cohorts for which smoking
data were available, the average joint effect
appears to be much closer to additive than
multiplicative. Nonetheless, the existing
scientific evidence is inadequate to either
establish or rule out any particular joint-
effect model.
Although a model ofconstant levels of
joint effect at various levels of smoking
would be more parsimonious, a nonlinear
model could also be considered, as well as
models under which the joint effect varies
with different temporal relationships
between smoking and radon exposure.
There may be theoretical support for a
model in which the interactive effects of
the two risk factors depend on level of
smoking. For example, ifbronchitis devel-
oping in the heaviest smokers results in a
mucous layer covering the respiratory
epithelium, this may protect the basal cell
layer from alpha-radiation.
Ifresidential radon is an important risk
factor for lung cancer, then the ability to
detect this main effect critically depends
on the unknown joint effect of radon and
smoking. The following hypothetical
example illustrates this phenomenon.
Suppose the incidence of lung cancer
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among radon-unexposed never-smokers is
10/100,000. Further suppose that the inci-
dence among unexposed smokers is
100/100,000 (smoking relative risk, Ro0s =
10), and that among radon-exposed never-
smokers is 20/100,000 (radon relative risk,
Rw1O = 2.0). If the true underlying joint
effect between radon and smoking is mul-
tiplicative, then, as shown in Table 1, the
incidence among exposed smokers would
be 200 and the relative risk oflung cancer
due to radon would be the same as for
never-smokers (Rs/RO's = 200/100 = 2.0).
On the other hand, under an additive
model, the incidence among smokers
would be 110/100,000, resulting in an
RV,/R0s of only 1.1 compared with the
radon relative risk of 2.0 among never-
smokers. Figure 1 illustrates the relation-
ship between the relative risk oflung can-
cer due to radon among smokers compared
with that among never-smokers under the
additive and multiplicative models.
As the calculations presented below
demonstrate, this effect could have dramat-
ic implications for the sample-size require-
ment of a case-control study. This mask-
ing ofa weak effect by a stronger one may
be considered an example ofthe phenome-
non underlying the advice ofRothman and
Poole (21) to restrict studies to lower-risk
populations in order to "strengthen weaker
associations."
Methods
Two case-control design options were
explored and are compared here: 1) carry-
ing out a study in a mixed population of
smokers and nonsmokers, made up of
approximately 40.4% current smokers,
31.1% former smokers, and 28.5% never-
smokers, and 2) carrying out a study
among never-smokers only. In the latter
case, it would of course be necessary to
include a screening stage in the fieldwork
plan to determine the smoking status of
potential subjects.
A series of computations were per-
formed, given the two design options, to
explore the implications of the aforemen-
tioned phenomenon on sample-size
requirements and costs. A number of
assumptions were made, as follows: 1) the
U.S. Environmental Protection Agency
National Residential Radon Survey (23)
was used to create a hypothetical distribu-
Table 1. Hypothetical joint effects of radon and smoking on lung cancer incidence rates (annual cases
per 100,000 population)
RR oflung cancer RR of lung cancer
Overall RR due to radon dueto radon
Smoker Radon Joint effect Incidence oflung cancer for nonsmokers forsmokers
No No Any 10 1
No Yes Any 20 2 2
Yes No Any 100 10
Yes Yes Multiplicative 200 20 2 2
Yes Yes Additive 110 11 2 1.1
RR, relative risk.
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Figure 1. Relative risk (RR) of radon exposure as a cause of lung cancer among smokers
never-smokers given additive and multiplicative models ofjoint effect between radon and s
tion of radon exposures grouped into 43
exposure level bins. 2) There are 146,000
annual U.S. lung cancer deaths (LCDs)
(24), and the varying proportions of these
are due to radon. The number of LCDs
attributed to radon is a direct function of
relative risk in the overall population. For
analyses under an additive model only, the
number of LCDs due to radon were
allowed to vary between 500 and 13,500.
For analyses under varying joint effect
models, the number ofLCDs due to radon
was fixed at 5,000. 3) The prevalences of
never, current, and former smoking were
taken to be 28.5%, 40.4%, and 31.1%,
respectively, based primarily on data avail-
able from the Surgeon General's report
(25). 4) Rs and Rf the relative risks oflung
cancer due to smoking among current and
former smokers, are assumed to be 19.22
and 8.52, respectively (25). 5) Exposures
to smoking and radon are independent. 6)
The relationship between radon exposure
and risk was assumed to be linear (consis-
tent with current concepts of dose effects
in radiation). 7) The model makes no
attempt to adjust for the effects ofpopula-
tion mobility and error in exposure assess-
ment.
When estimating sample size, it is nec-
essary to fix some level ofexcess risk as the
detectable level of the effect to be exam-
ined. It is customary to use the relative risk
as the parameter to be fixed. However, for
the purpose ofthis analysis, it was consid-
ered more appropriate to use the attribut-
able risk because the relative risk ofa high
prevalence exposure in the general popula-
tion may not be as relevant as the overall
public health impact of the exposure. For
an exposure as prevalent as radon, even a
very low relative risk can result in a high
attributable risk. For example, at an Rv of
1.1 among those exposed to the top quar-
tile ofradon levels, there would be almost
7,000 annual U.S. lung cancer deaths.
While the failure to detect a relative risk as
low as 1.1 might seem acceptable for many
occupational or environmental exposures,
this would result in a significant undetect-
ed hazard in the case ofradon. The follow-
ing formula expresses the joint effect of
smoking and radon:
Rw, =[R0 XR0]qX [RW +ROs -q
tive_
where q = 0 represents an additive joint
effect, and q = 1 represents a multiplicative
joint effect (6) (the analogous formulawith
"f* substituted for "s" was used for the
joint effect ofradon and formersmoking).
1.9 2 Because the value of q is unknown, it was
allowed to vary between 0 and 1.2 to cover
the range between additive and supramul-
compared with tiplicative.
smoking. Sample size and power estimates were
Volume 103, Number 1, January 1995 59calculated using the continuous exposure
model method ofLubin et al. (26). Given
each set ofthe quantities specified above,
expected distributions ofradon exposures
for cases and controls were generated and
used to calculate sample size require-
ments to detect a radon effect, assuming
80% power, a 1:1 case-control ratio, and
a two-tailed a = 0.05. These calculations
are described in greater detail in the
appendix. The computations were imple-
mented using Microsoft Excel version 5.0
(Microsoft Corporation, Redmond,
Washington).
Once the sample sizes were estimated,
additional computations were performed
to investigate the anticipated relative costs
of various case-control studies roughly
based on estimates obtained from a pilot
case-control study of never-smokers in
Michigan. For the purpose of this paper,
the cost estimates include the labor and
materials associated with data collection
(interviewing, field work, coordination),
and do not include the costs ofdata analy-
sis (principle and co-investigators, consul-
tants), nor do these costs include institu-
tional indirect costs. It was assumed that
cases would be identified through the
abstracting of hospital and clinic records,
using an existing tumor registry system
(e.g., a Surveillance, Epidemiology, and
End Results Program database), and that
these subjects would be subsequently inter-
viewed to screen for smoking status. The
costs for case ascertainment include the
labor and materials to abstract information
from hospital charts for all lung cancer
cases, mail letters to physicians prior to
patient contact, and coordinate the project.
For never-smoker cases, costs would be
much higher because approximately 20
times as manylung cancer patients must be
identified to yield an equal number of
never-smoker cases. Further, a brief tele-
phone screening interview must be per-
formed to identify smoking status. While
cases drawn from the general population of
lung cancer patients might cost only $30
each to ascertain, the never-smoker cases
would cost approximately $400 each. The
cost ratio (for ascertaining never-smoker
cases versus all cases) is lower than 20:1
because of economies of scale and other
operational factors which reduce the per
registry patient cost ofenrolling subjects in
the never-smoker cohort. Control ascer-
tainment would be through random-digit
dialing methods and may be ofsimilar cost
in either study because smoking status
would need to be matched in either case.
Exposure assessment would be similar
regardless of subject status as a case, con-
trol, smoker, or never-smoker. This would
require a lengthy interview ofeach subject,
the identification and tracking of each of
their prior residences (2.7 homes per sub-
ject), gaining entry to each home, deploy-
ment of an alpha-track measurement
device, administration of a home survey,
repeated telephone contacts during the
year of measurement, collection of detec-
tors from each home, along with an updat-
ed home survey, data entry, and project
coordination.
Table 2 lists the costs that were
assumed for subjects in each of the two
study designs under consideration. Costs
are provided for both never-smokers and a
mixed population of smokers and non-
smokers (in naturally occurring propor-
tions).
Results
Under the assumptions listed in Methods,
and assuming an additive joint-effect
model with an attributable risk of 5000
annual lung cancer deaths per year, only
111 cases and controls would be required if
never-smokers were studied. If a similar
study were conducted in a mixed smoker
and nonsmoker population, however, the
sample size required would increase to
5651 cases and controls. If the underlying
joint-effect model were not additive and
the attributable risk were nonetheless fixed
at 5000 annual cases, the sample-size
requirement would remain constant at
5651 in the mixed population but would
vary for never-smokers depending on the
joint effect between radon and smoking.
Under the additive model, only 111 cases
and controls would be required, while
under a multiplicative model, 5651 would
be required. Figure 2 shows sample-size
requirements for different values of the
joint-effect parameter. With a fixed num-
ber ofannual lung cancer deaths, the over-
all relative risk oflung cancer due to radon
in the general population remains fixed,
explaining the constant sample-size
requirement under conditions of a mixed
population. On the other hand, if a study
were limited to never-smokers, the sample-
size requirement would depend on the rel-
ative risk of radon among never-smokers.
With the overall relative risk oflung cancer
due to radon (R,) fixed, the relative risk
among never-smokers (Rk,) will decrease,
while the relative risk among smokers
(RkS) will increase, as the joint-effect para-
meter varies from additive (q = 0) to multi-
plicative (q = 1). As a result, the sample-
size requirement is relatively low (111)
when radon is responsible for 5000 annual
LCDs under an additive model, whereas it
is considerable (5651) when the same
number ofdeaths are attributed under the
multiplicative model. If the joint effect
were taken to be 0.19 [the average of the
joint-effect parameters reported by the
recent report (3) of the National Cancer
Table 2. Estimated costs of identifying subjects and obtaining exposure measurements
Never-smokers
Cases
Controls
Subject
ascertainment
$650
$150
Exposure
assessment
$1200
$1200
Mixed population
Subject Exposure
ascertainment assessment
$50 $1200
$150 $1200
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Figure 2. Sample size requirements for case-control studies of lung cancer patients. in order to detect a
risk level which would result in 5000 annual U.S. lung cancer deaths due to radon, as function of joint
effect(0 = additive; 1 =multiplicative).
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Institute], then the sample-size require-
ment would be 577 in a never-smoker
study and 5651 in a mixed population
study.
Assuming a purely additive model,
Figure 3 presents the sample-size require-
ments as a function of the potency of
radon as a carcinogen (expressed as a vary-
ing attributable risk) for both never-smok-
ers and a mixed population. The analysis
demonstrates that under the additive model,
studying never-smokers would require up to
two orders of magnitude fewer subjects
than studying a mixed population, irre-
spective of the level of relative or attribut-
able risk within the range of attributable
risks studied (500 to 13,500 attributable
cases per year).
Figure 4 presents cost estimates for
identifying subjects and assessing exposure
in studies among never-smokers and the
general population of lung cancer cases,
based on the estimated sample-size require-
ments of Figure 2. A considerable savings
can be appreciated for studies restricted to
never-smokers when the joint effect is sub-
multiplicative. In fact, if the true joint
effect is approximately 0.19, as suggested
by the weighted average of the joint-effect
parameters found in the mining studies
(3), then the cost estimate for a study of
never-smokers is approximately eight times
lower than a comparable study ofa mixed
population of current smokers, former
smokers, and never-smokers.
Discussion
A large number of studies have been
undertaken to examine the relationship
between domestic radon and lung cancer.
Since the vast majority of lung cancer
patients (typically 95%) are or were smok-
ers, most ofthese studies are dominated by
smokers. If the joint effect between radon
and smoking is multiplicative or supramul-
tiplicative, some of these studies would
have sufficient power to detect reasonable
relative risks of lung cancer due to radon.
On the other hand, if the joint effect is
closer to additive, then it is unlikely that
any ofthe current studies would have ade-
quate power to detect the effect at risk lev-
els that would be of public health impor-
tance. This could inappropriately lead to
the conclusion that residential radon does
not pose a significant carcinogenic risk.
One solution to this dilemma may be
to increase sample sizes with additional
studies among smokers. However, given
the high cost of exposure assessment for
radon, it would be more cost effective to
study a smaller cohort of never-smokers.
This advantage appears to hold for most
levels of joint effect below multiplicative,
even though the cost ofcase ascertainment
for never-smokers is high (it generally
1.usA
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Annual U.S. lung cancers attributed to radon
Figure 3. Sample size requirements as a function of lung cancer risk (expressed as annual number of U.S.
lung cancer deaths attributed radon), given an additive model ofjoint effect.
$1000000
$OMs.mu.
u at
S.
sIA..m
$100o.i
1.2 0 02 0.4 0s 0.8
Jointeffectparameter
Figure 4. Estimated cost of identifying subjects and assessing exposure for a case-control study, given
5000 annual U.S. lung cancer deaths attributed to radon.
requires screening 20 cases to identify one
never-smoker). Depending upon the sam-
ple size required (based upon the underly-
ing joint effect), the difference in cost
between studying smokers compared with
never-smokers could be considerable.
It may be that meta-analysis could
extract additional useful information about
the effect of radon among never-smokers.
However, even when existing case-control
studies are pooled, the total number of
never-smokers remains small. This factor,
and the usual heterogeneity of data
sources, may still preclude a definitive con-
clusion about radon and lung cancer from
a meta-analysis.
Another alternative might be to over-
sample never-smokers using a randomized
recruitment approach to probability
matching on smoking status, as suggested
by Weinberg and Sandler (27). Such an
approach would allow one to take advan-
tage of the extra information the never-
smokers would provide if an additive (or
submultiplicative) joint effect holds. This
extra information is reflected in the con-
trasting sample sizes of 111 for never-
smokers versus 5651 for smokers. Ifa sam-
ple size between these two extremes could
be afforded, including data on smokers
collected in the same study might allow for
assessment ofinteraction. However, such a
study would have a sample-size require-
ment of greater than 111 for the never-
smoker stratum, since either the main
effect estimate would be diluted by a much
smaller effect ofradon among the smokers,
or a multiple comparison adjustment
would be indicated for the separate sub-
group tests.
Ifthere had been no previous investiga-
tions, then the case for studying never-
smokers versus smokers would not be as
clearcut. In fact, it may be argued that these
Volume 103, Number 1, January 1995 61- 9.J i E S1
strategies evaluate different hypotheses.
While the smoker study would also be able
to examine the hypothesis ofjoint effect of
smoking and radon, the never-smoker
study may have greater power to examine
the main effect of radon alone. Further, a
never-smoker study might provide an
opportunity to simultaneously examine the
effects ofpassive smoking, which could not
be examined among smokers, since the
effect would be overwhelmed by the much
stronger effect ofactive smoking.
The current ongoing studies may be
adequate to evaluate the risk of radon
among smokers ifthe joint smoking-radon
effect is close to multiplicative. However, if
the true joint effect between smoking and
radon is close to additive, it would be more
cost-effective to study never-smokers.
Although case ascertainment costs would
be considerably higher in a never-smoker
study, this would be more than offset by
the reduced sample-size requirement,
which would reduce exposure assessment
costs. However, a joint effect close to addi-
tive would also imply that the public
health burden of radon as a lung carcino-
gen, as measured by the number ofattrib-
utable cases, is less than it would be ifthe
true joint effect approaches a multiplicative
or supramultiplicative model. In this sense,
the need to detect the risk associated with
radon may be greater if the multiplicative
model were correct.
Nevertheless, under the additive
model, radon could be responsible for a
large number of annual lung cancer cases,
which would be extremely difficult to
detect with a study of smokers. As previ-
ously mentioned, under an additive model,
even very low relative risk levels can result
in considerable mortality due to the large
population exposed to radon and the high
overall lung cancer mortality rate.
The present evaluation of differential
costs for studies using different strategies
was predicated on several simplifying
assumptions, and varying these assump-
tions could affect the conclusions. First,
the actual costs of screening for never-
smokers and performing other aspects of
an investigation may vary depending on
where the study is undertaken. The relative
advantages of one strategy over another
may be affected if relative costs were very
different from those assumed in Table 2.
The estimates used in this analysis were
based on an investigation performed at a
center with a tumor registry having the
capabilities for rapid reporting oflung can-
cer cases. If an abstracting unit were not
already in existence, then the costs of case
ascertainment could be much higher, and
this could affect the relative cost effective-
ness ofthe study design being considered.
Second, a variety ofother factors which
may increase sample-size requirements
have not been considered in this analysis,
including measurement error in the use of
alpha-track devices, use ofcurrent exposure
data as a surrogate for historic exposure,
error in the reconstruction of home occu-
pancy dates, loss ofdata on exposure (e.g.,
homes may be unavailable for measure-
ment; occupancy durations may not meet
inclusion criteria for study), use ofambient
measurements in fixed locations rather
than where the subjects actually spent their
time (both within the home and outside
the home), inadequacy of ambient radon
levels as a measure ofalpha radiation dose
to the respiratory epithelium, use ofradon
gas measurements as a surrogate for radon
progeny exposure, error associated with
estimating the temporal association
between radon and lung cancer (e.g., laten-
cy periods), inadequate accounting of
other carcinogenic exposures (e.g. inaccu-
rate active or passive smoking histories),
age effects, and nonresidential radon expo-
sures. Further, variations of the additional
assumptions described in the Methods sec-
tion could impact the outcomes. Although
such factors and others may have a signifi-
cant effect on ultimate sample size require-
ments, they should not affect the compari-
son ofdesign strategies.
Although the focus of this paper was
on radon and lung cancer, the underlying
principles apply more generally. The
assessment of sample size for case-control
studies is usually based on an implicit
assumption that the risk factor under study
interacts in a multiplicative fashion with
other risk factors. When this assumption of
multiplicity does not hold, sample size esti-
mates may not be accurate. When the joint
effect is less than multiplicative, larger
samples may be required, or else the study
could be restricted to a subgroup in which
the other risk factors are absent. The opti-
mal approach would depend on the rela-
tive costs of identifying and studying the
subgroup as compared with a larger, unre-
stricted cohort. Unless models other than
multiplicative are considered, negative
study outcomes may not support the con-
clusion that an association is absent. A lack
of association cannot always be inferred
until the body ofstudies includes a reason-
able complement ofapproaches.
In addition to selecting the population
based on smoking status, investigators
should also consider other important
design issues. The regions for study should
have relatively high and heterogeneous
exposure levels. This analysis was based on
the national exposure distribution in the
United States. However, sample-size
requirements may be reduced for studies
carried out in areas with higher exposure
levels. Because population mobility will
homogenize exposure and reduce study
power (6), areas with low mobility are pre-
ferred. Effort must be made to maximize
yield and minimize missing data in the
reconstruction of the residential histories
and in the placement ofradon detectors in
homes. The most commonly recommend-
ed method for exposure assessment is the
year-long alpha-track measurement (28).
However, such measurements examine
only current exposure at fixed ambient
locations in the home. A possible comple-
mentary method ofexposure measurement
might include the use ofheirloom glass or
porcelain objects as dosimeters, or mea-
surements of lead-210 emissions made in
vivo (29). The relationship between these
measurements and actual historic cumula-
tive dose to the human respiratory epitheli-
um is notwell established.
In conclusion, given the lack of well-
designed studies restricted to never-smok-
ers, such an investigation may be indicated
to examine the hypothesis that radon poses
a significant public health risk to both
smokers and nonsmokers under a submul-
tiplicative, additive, or nonlinear model of
joint effect between radon and smoking.
Appendix
The following are details ofthe steps taken
to establish the sample size estimates
reported in this publication:
Step 1:Startingassumptions:
Annual U.S. lungcancerdeaths: 146,000 C
Lifetime lung cancer mortality rates (per
100,000):
Currentsmokers: 10,329
Formersmokers: 4,579
Neversmokers: 537
Mixedpopulation: 4,433
Relative risks forlung cancerdeaths:
Currentsmokersvs. neversmokers: 19.22
Formersmokersvs. neversmokers: 8.52
Mixed population vs. neversmokers: 8.25
Prevalence ofcurrentsmokers: 40.4%
Prevalence offormersmokers: 31.1%
Prevalence ofneversmokers: 28.5%
p
Pn
Which implies a lung cancer death distribu-
tion of:
Current smokers: 105,920 CS
Former smokers: 36,191 Cf
Neversmokers: 3,890 Cn
Step 2: A hypothesized number of cancers
due to radon is assumed, and the lung cancer
relative risk due to radon averaged over cur-
rent, former, and never smokers is calculated.
For instance, 15,000 annual lung cancer
deaths due to radon might be assumed. The
implied average radon relative risk, R,, is
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computed, i.e.: 146,000/(146,000 - 15,000)
= 1.1145.
These 15,000 (C) radon lung cancers must
be distributed among current smokers (C ),
former smokers (Cf) and never smokers
(Cr~n): Cr = Cr,S + Cref + Cr,n
It maybe noted that
Cnr
= Cn. w (q/k,o
and
RoS= [(Cs- Crs)/s][(Cn- Cq)IPi]
Rof= [(Cf-C;,f)/Pf]/[(C
- Crn)/Pn]
and
RESTS (C's)/l(Cn
-Crnd/n]
but also,
RwS = [Rw0o XROs]q X [Rw o+ROs -1]1-q
Step 3: From the above relationships, the
quantities Crs Cr and Cr n may be comput-
ed.
Step 4: The quantities C , C f, and C are r~~s' r~f' r,n
then used to impute the distributions of
radon exposure levels for current smokers,
former smokers, and never smokers. These
are in turn used to compute power or sample
size using the Lubin method (26).
The starting point for the exposure distribu-
tions is the recent EPA residential radon sur-
vey data (30). The exposure levels were
grouped into convenient intervals ofvarying
widths. Cutpoints were 0, 0.0625, 0.125, . . .
1.0, 1.25, 1.5, 1.75, 2.0, 2.5, 3.0, . . . 5.0,
6.0, 7.0, ... 30.0, and 53.0 pCi/i. All sub-
jects in an interval were assumed to have been
exposed to the midpoint value, except for the
last interval, where the exposure was 53.0
pCi/i.
It is assumed that the rate of radon-induced
lung cancer is linearly related to the exposure
level. Therefore, the proportion oflung can-
cers in the ith interval is estimated to be:
CI/C= (Cr/C)(HI)(E.)/(SHlE,)
+( -CQIC)(HI)I(SHi)
where Hi is the proportion ofhomes in the
ith exposure interval. If C , Ctf and C;n are
substituted for Cr, and Crs C, and C, f~or C,
respectively, in the above formula, propor-
tions of lung cancers at each exposure level
for current, former, and never smokers may
beestimated.
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